Literature DB >> 19450659

Microtubule-associated protein tau (MAPT) influences the risk of Parkinson's disease among Indians.

Gautami Das1, Amar K Misra, Shyamal K Das, Kunal Ray, Jharna Ray.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease of the central nervous system and its prevalence increases with age. Microtubule-associated protein tau (MAPT), a neuronal protein is involved in the pathogenesis of several neurodegenerative diseases including PD. To determine the broader significance of this association with PD, replicative studies in distinct ethnic populations are required. In this study, we investigated MAPT for its potential association with PD using five haplotype-tagging SNPs and the del-In9 polymorphism of MAPT in 301 PD patients and 243 healthy controls from eastern India. Our case-control analysis did not show a significant association with any of the markers and PD. However, a risk haplotype [GAC+G] for PD was identified (OR=1.563; 95% CI=1.045-2.337; p=0.03). In addition, haplotype AAC+A (OR=2.787; 95% CI=1.372-5.655; p=0.004) was strongly associated with early onset PD (age at onset < or =40 years) and AAC+G haplotype showed a weak association (OR=2.233; 95% CI=1.018-4.895; p=0.045) with late onset PD (age at onset >40 years). This observation highlights the significance of rs7521 in modifying the age at onset of PD under a common haplotype background. We also identified AGC+A as a risk haplotype for sporadic cases (OR=2.773, 95% CI=1.198-6.407, p=0.016). This is the first association study from India conducted on MAPT among PD patients and provides valuable information for comparison with other ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19450659     DOI: 10.1016/j.neulet.2009.05.031

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  Role of Apolipoprotein E, Cathepsin D, and Brain-Derived Neurotrophic Factor in Parkinson's Disease: A Study from Eastern India.

Authors:  Prosenjit Pal; Tamal Sadhukhan; Subhadip Chakraborty; Sriparna Sadhukhan; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  Neuromolecular Med       Date:  2019-05-28       Impact factor: 3.843

2.  Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.

Authors:  Albert A Davis; Kristin M Andruska; Bruno A Benitez; Brad A Racette; Joel S Perlmutter; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2015-09-30       Impact factor: 4.673

3.  Family-based association analysis of the MAPT gene in Parkinson disease.

Authors:  K S Wang; J E Mullersman; X F Liu
Journal:  J Appl Genet       Date:  2010       Impact factor: 2.653

Review 4.  Research in Parkinson's disease in India: A review.

Authors:  Pratibha Surathi; Ketan Jhunjhunwala; Ravi Yadav; Pramod Kumar Pal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jan-Mar       Impact factor: 1.383

Review 5.  Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Authors:  Cheng-Cheng Zhang; Jun-Xia Zhu; Yu Wan; Lin Tan; Hui-Fu Wang; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2017-07-04

Review 6.  Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.

Authors:  Fatemeh N Emamzadeh; Andrei Surguchov
Journal:  Front Neurosci       Date:  2018-08-30       Impact factor: 4.677

Review 7.  Molecular landscape of long noncoding RNAs in brain disorders.

Authors:  Sumin Yang; Key-Hwan Lim; Sung-Hyun Kim; Jae-Yeol Joo
Journal:  Mol Psychiatry       Date:  2020-11-10       Impact factor: 15.992

8.  Genetic Architecture of MAPT Gene Region in Parkinson Disease Subtypes.

Authors:  Esterina Pascale; Maria Elena Di Battista; Alfonso Rubino; Carlo Purcaro; Marcella Valente; Francesco Fattapposta; Giampiero Ferraguti; Giuseppe Meco
Journal:  Front Cell Neurosci       Date:  2016-04-11       Impact factor: 5.505

9.  Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression.

Authors:  Tingting Ye; Yifei Cheng; Chao Li
Journal:  Comput Math Methods Med       Date:  2021-07-29       Impact factor: 2.238

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.